Today was pretty exciting with all the news out of India and potential immediate EUA while a small trial takes place. Immediate revenue sounds great. Funny how we can have a quick small trial in other countries when our last trials showed great results although we had small groups and not judged well for what they were worth. Begs the question of why? Do other countries not trust our FDA after multiple EUA’s that were not continued after quick approvals? Is the reputation of our FDA not the Gold Standard anymore? How many drugs did other countries buy from USA big Pharma and the value was retracted or EUA removed?

No matter how we view it or others view it. The stain of not approving Leronlimab on our past results with no harm from our perfect drug safety will be heavily weighed on to our FDA. Asleep at the wheel yet again.

Oh well, we will take the international journey and throw dust into our exit as we furnish “the drug that almost seems like it was designed for covid” as quoted by Dr. Patterson. All others will just be piecemeal and not compare to Leronlimab. It may take 3 or more drugs to equal Leronlimab. I just wonder if that Tedx presentation has been forwarded to any suitors internationally? Because if they haven’t seen the video that hooked me hard on Leronlimab... they should...

GLTA